PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 0.9350
-0.0050 (-0.53%)
Mar 18, 2026, 4:10 PM AEST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 645.94 million as of March 18, 2026. Its market cap has decreased by -34.62% in one year.
Market Cap
645.94M
Enterprise Value
634.86M
Revenue
139.49M
Ranking
n/a
PE Ratio
66.45
Stock Price
0.94
Market Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 645.94M, an increase of 1,852.23%. That is a compound annual growth rate of 11.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 649.39M | -23.58% |
| Dec 31, 2025 | 849.74M | -39.71% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4DMedical | 2.34B |
| Anteris Technologies Global | 884.81M |
| Lumos Diagnostics Holdings | 223.36M |
| Aroa Biosurgery | 207.29M |
| Epiminder | 151.45M |
| EMVision Medical Devices | 146.84M |
| SomnoMed | 144.17M |
| Cleo Diagnostics | 68.43M |